NEW YORK , Oct. 24 – Affymetrix reported flat third-quarter revenues despite increasing sales of its GeneChip product increased, the company said on Wednesday.
Affy's overall third-quarter revenues totaled $55.4 million, compared to $55.8 million for the same period one year ago. Product revenue increased to $47.3 million from $45.4 million for the year-ago quarter, the company said.
Registering provides access to this and other free content.
Already have an account?Login Now.
The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.
Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.
Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.
In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.